Peer-reviewed veterinary case report
Hindering triple negative breast cancer progression by targeting endogenous interleukin-30 requires IFNγ signaling.
- Journal:
- Clinical and translational medicine
- Year:
- 2021
- Authors:
- Sorrentino, Carlo et al.
- Affiliation:
- Department of Medicine and Sciences of Aging · Italy
Abstract
IL30mRNA expression is associated with the TNBC subtype. IL30 boosts proliferation and migration of TNBC cells and reshapes their immunity gene expression profile. The lack of endogenous IL30 hinders TNBC growth and progression and prolongs host survival. TNBC growth inhibition, due to the lack of endogenous IL30, requires INFγ production by T and NK cells.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication: https://pubmed.ncbi.nlm.nih.gov/33635005/